Industry News 2019-02-14T03:28:07+00:00

Industry News

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

Digital Therapeutics Alliance boosts European presence

DUBLIN, IRELAND - 16 October 2018 - S3 Connected Health News - Digital Therapeutics Alliance (DTA) boosts Europe presence to advance the adoption of evidence-based digital therapeutics S3 Connected Health, a DTA member, is working alongside fellow [...]

Digital Therapeutics Alliance and USP Announce Collaboration

WASHINGTON, June 4, 2018 /PRNewswire-USNewswire/ – The Digital Therapeutics Alliance (DTA) and USP announced a collaboration to explore the development of appropriate standards and guidelines for digital therapeutics at a roundtable discussion co-hosted by the [...]

The Digital Therapeutics Alliance Announces New Members

Arlington, VA — May 8, 2018 — The Digital Therapeutics Alliance welcomes nine companies to membership: Bayer, Big Health, Cognoa, Kaia Health, Merck, Omada Health, Otsuka America Pharmaceutical, Inc., Pear Therapeutics, and Sanofi. “Digital medicine has the [...]

DTA Opens Membership to Enhance Industry Growth and Direction

The Digital Therapeutics Alliance (DTA), a global non-profit trade association that represents the healthcare industry’s leading digital therapeutics manufacturers, announces today the expansion of its membership to a diverse group of organizations dedicated to broadening [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

BIO conference shines a brighter spotlight on digital health

STAT News (Kate Sheridan) -- Leaders like J.P. Morgan’s Jamie Dimon, acting Food and Drug Administration Commissioner Ned Sharpless, and researcher and author Dr. Siddhartha Mukherjee may be the marquee names at the biotech industry’s [...]

Pharma execs are bullish on digital therapeutics

Nicky Lineaweaver/Business Insider - Digital therapeutics has caught the eye of pharmaceutical companies as a potential balm to a host of the pharma industry's struggles, according to MedCity News. Digital therapeutics is a category of software — [...]

Load More Posts

DTx Research & Studies

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Load More Posts

Stay Up To Date


Sign Up Now